TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.


2nd International Conference and Exhibition on Antibodies

July 11–12, 2016 | Philadelphia, PA

BioPharm America 2016

September 13–15 | Boston, MA

AusBiotech 2016

October 24–26 | Victoria, Australia

PEGS Summit – Europe

October 31-November 4 |  Lisbon, Portugal